Abstract Background: Coronary artery calcification (CAC) represents a distinct imaging phenotype reflecting advanced vascular remodeling, particularly in patients with chronic kidney disease (CKD). However, metabolic determinants linking renal dysfunction to CAC remain incompletely understood. Ceramides, bioactive sphingolipids involved in vascular inflammation and calcification, may represent potential mediators of this interaction.
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile